CMR Surgical Appoints Chris O’Hara to Lead U.S. Commercial Operations

UK-based CMR Surgical has appointed Chris O’Hara as Commercial President and General Manager for the U.S., a newly created role that places him at the forefront of the company’s expansion into one of the world’s largest surgical robotics markets. He will report directly to CEO Massimiliano Colella.

O’Hara brings over two decades of leadership experience in the medical device sector, including senior commercial roles at Virtual Incision, Intuitive Surgical, Globus Medical, and Cardiovascular Systems. He has built a track record of scaling sales and marketing operations in competitive markets, expertise that will be central as CMR grows its U.S. presence.

CMR recently received FDA authorization for its Versius surgical robot, which has already been used in more than 36,000 procedures worldwide. With demand accelerating, the company is preparing for wider U.S. adoption, where O’Hara will oversee strategy and execution.

Colella welcomed the appointment, calling it a timely move to strengthen commercial operations as CMR enters a new phase of growth. O’Hara expressed enthusiasm for joining the company, noting that CMR’s innovation and international reach provide a strong foundation to establish Versius in the U.S. market.